Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage.

Source:http://linkedlifedata.com/resource/pubmed/id/11368433

Download in:

View as

General Info

PMID
11368433